Head and Neck Squamous Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Head and Neck Squamous Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2013-04-05Clinical Trial Update: Phase II Study of Cetuximab With or Without OSI-906 in Head and Neck Squamous Cell Carcinoma (HNSCC) [Phase 2]
A Phase II trial evaluating cetuximab with or without OSI-906 in head and neck squamous cell carcinoma has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2013-04-02Clinical Trial Update: Cisplatin and Radiation Therapy With or Without Erlotinib Hydrochloride in Treating Patients With Stage III or Stage IV Head and Neck Cancer [Phase 2]
Phase 2 trial assessing whether adding erlotinib to cisplatin-based radiation improves outcomes in stage III/IV head and neck squamous cell …
-
CLINICAL_TRIALS research · 2013-04-02Clinical Trial Update: Blood Proteins in Predicting Treatment Benefit in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer
This update describes a completed clinical trial investigating whether specific blood protein biomarkers can predict treatment benefit in pa…
-
CLINICAL_TRIALS research · 2013-04-02Clinical Trial Update: Biomarkers in Predicting Response to Treatment in Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer Treated With Carboplatin, Paclitaxel, and Radiation Therapy
Clinical trial update on biomarkers that may predict response to treatment in newly diagnosed stage III/IV head and neck cancer treated with…
-
CLINICAL_TRIALS trial_result · 2013-03-19Clinical Trial Update: A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer [Phase 2]
Results from a Phase 2 trial for recurrent or metastatic head and neck squamous cell carcinoma sponsored by Eli Lilly; trial has completed a…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-02-27Clinical Trial Update: Ixabepilone in Treating Patients With Metastatic or Recurrent Squamous Cell Cancer of the Head and Neck [Phase 2]
Phase 2 trial update evaluating ixabepilone in patients with metastatic or recurrent head and neck squamous cell carcinoma; the study has co…
-
CLINICAL_TRIALS trial_result · 2013-01-09Clinical Trial Update: Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer, Ovarian Cancer, or Squamous Cell Carcinoma of the Head and Neck [Phase 1, Phase 2]
Clinical trial updates show Erlotinib tested in patients with advanced Non-small Cell Lung Cancer, Ovarian Epithelial Cancer, and Head and N…
-
CLINICAL_TRIALS trial_result · 2012-11-14Clinical Trial Update: Neoadjuvant Cetuximab in HNSCC Combined With Curative Surgery [Phase 1, Phase 2]
This document reports on a completed Phase 1/2 trial evaluating neoadjuvant cetuximab followed by curative surgery in head and neck squamous…
-
CLINICAL_TRIALS trial_result · 2012-11-14Clinical Trial Update: Profile of Plasma Growth Factors Before and After Head and Neck Oncological or Non-oncological Surgery [Phase 1, Phase 2]
A completed Phase 1/2 trial profiling plasma growth factors before and after head and neck surgery in patients with head and neck squamous c…
-
CLINICAL_TRIALS trial_result · 2012-11-14Clinical Trial Update: MRX, Radiation, and Chemotherapy for Patients With Resected Squamous Cell Carcinoma of the Head and Neck [Phase 1]
A Phase 1 study evaluating MRX with radiation and chemotherapy for patients with resected head and neck squamous cell carcinoma was terminat…
-
CLINICAL_TRIALS research · 2012-10-08Clinical Trial Update: Study of BKM120 in Advanced Squamous Cell Carcinoma of Head and Neck [Phase 2]
A Phase 2 clinical trial investigating buparlisib (BKM120) in advanced head and neck squamous cell carcinoma is listed. The current study st…
-
CLINICAL_TRIALS research · 2012-10-02Clinical Trial Update: Evaluation of the Oncoral® Test in Epidermoid Carcinomas of the Upper Aerodigestive Tract [NA]
This clinical trial update reports an evaluation of the Oncoral Test for epidermoid carcinomas of the upper aerodigestive tract. No results …
-
CLINICAL_TRIALS research · 2012-09-10Clinical Trial Update: A Retrospective Analysis of Neck Dissection Following Complete Response to Chemoradiation in HNSCC
A retrospective analysis evaluating neck dissection after complete response to chemoradiation in head and neck squamous cell carcinoma.
-
CLINICAL_TRIALS research · 2012-09-05Clinical Trial Update: Head and Neck Cancer Screening and Serum Repository
Update on a completed clinical trial evaluating screening and a serum repository for head and neck squamous cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2012-08-14Clinical Trial Update: Cetuximab With Radiotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck in Chinese Subjects [Phase 3]
This Phase 3 trial update reports the results of adding cetuximab to radiotherapy for locally advanced head and neck squamous cell carcinoma…
-
CLINICAL_TRIALS trial_result · 2012-08-10Clinical Trial Update: A Trial to Determine the Safety and Anti-tumor Activity Profile of the Combination of Cetuximab and Concomitant Cisplatin Plus 5-Fluorouracil (5-FU) in Subjects With Recurrent and/or Metastatic Squamous Cell Carcinoma in Head and Neck [Phase 3]
Phase 3 trial evaluating safety and anti-tumor activity of cetuximab in combination with cisplatin and 5-fluorouracil in recurrent and/or me…
-
CLINICAL_TRIALS withdrawal · 2012-08-01Clinical Trial Update: Assessment of Head and Neck Tumor Hypoxia Using 18F-Fluoromisonidazole [NA]
A clinical trial evaluating head and neck tumor hypoxia with the PET tracer 18F-Fluoromisonidazole has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2012-07-11Clinical Trial Update: Cetuximab and Everolimus in Treating Patients With Metastatic or Recurrent Colon Cancer or Head and Neck Cancer [Phase 1]
A Phase 1 clinical trial update reports completion of a study evaluating cetuximab in combination with everolimus for patients with metastat…
-
CLINICAL_TRIALS trial_result · 2012-07-09Clinical Trial Update: Cervical Nodal Mets in Squamous Cell Carcinoma of H&N - MRI, FDG-PET, & Histopathologic Correlation [NA]
This completed clinical trial from Stanford evaluates the correlation between MRI, FDG-PET imaging, and histopathology for cervical nodal me…
-
CLINICAL_TRIALS withdrawal · 2012-05-30Clinical Trial Update: Phase I Study of Olaparib With Cisplatin Based Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck [Phase 1]
A Phase I trial of Olaparib in combination with cisplatin-based chemoradiotherapy for head and neck squamous cell carcinoma has been withdra…
-
CLINICAL_TRIALS trial_result · 2012-05-14Clinical Trial Update: DAHANCA 24: Prognostic Value of 18F-FAZA in Head and Neck Squamous Cell Carcinoma (HNSCC)
A DAHANCA trial update evaluating the prognostic value of the PET tracer 18F-FAZA in head and neck squamous cell carcinoma (HNSCC).
-
FDA approval · 2012-03-15FDA Approved: CISPLATIN — Supplemental Application (Teva Parenteral Medicines, Inc.)
FDA approved a supplemental application for cisplatin from Teva Parenteral Medicines, Inc., marking an approved change to the drug's regulat…
-
CLINICAL_TRIALS trial_result · 2012-02-27Clinical Trial Update: Erlotinib and Docetaxel With Concomitant Boost Radiation Therapy (XRT) for Head and Neck Squamous Cell Carcinoma (HNSCC) [Phase 1]
A Phase 1 study evaluating erlotinib and docetaxel with concomitant boost radiation therapy for head and neck squamous cell carcinoma has co…
-
CLINICAL_TRIALS trial_result · 2012-02-20Clinical Trial Update: Induction Chemotherapy With Nimotuzumab in Locally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC) [Phase 2]
Phase 2 trial evaluating induction chemotherapy with nimotuzumab in locally advanced head and neck squamous cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2011-12-23Clinical Trial Update: Zalutumumab in Combination With Chemotherapy and Radiotherapy in Head and Neck Cancer [Phase 1, Phase 2]
Phase 1/2 trial of zalutumumab in combination with chemotherapy and radiotherapy for head and neck squamous cell carcinoma was terminated; r…